Small Uptick In 510(k) Clearances In Fiscal 2014
This article was originally published in The Gray Sheet
Executive Summary
FDA cleared 3,103 510(k)s in the fiscal year that ended Sept. 30, averaging about 259 per month, based on a review a FDA’s monthly 510(k) listings. That is up from 2,995 clearances – a 250 per-month average – in FY 2013.
You may also be interested in...
FDA Reports Declining 510(k) Times, And Other Improvements
The most recent user-fee program trends report from FDA, with data current to March 31, 2014, shows improvements in 510(k) review metrics.
FDA Plans To Audit Its New 510(k) Refuse-To-Accept Program
Results of the planned June audit will be of significant interest to a number of device companies that claim FDA reviewers have erroneously crossed into substantive review territory in applying the new "quick review" procedure.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.